ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Mainfreight Ltd (PK)

Mainfreight Ltd (PK) (MFGHY)

0.00
0.00
(0.00%)
Closed March 25 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

MFGHY News

Official News Only
0 articles were found

Discussion

View Full Feed
catdaddy catdaddy 5 minutes ago
Right, and you’re in the know.
AVXL
Paulie Cashews Paulie Cashews 6 minutes ago
I never confuse education with intelligence. You can have a Master's degree, and still be an idiot.

adserv.stocksite.com/images/paulie/scroll.jpg

www.investorshub.com/boards/board.asp?board_id=2581 Paulie's Pixel Palace
janice shell janice shell 6 minutes ago
I think that's a pretty fair assessment.
WALL STREET KID WALL STREET KID 7 minutes ago
In 2024, Tesla, Ford, Honda, and Stellantis (Chrysler/Dodge/Jeep/Ram) led in the number of vehicles recalled.

Here's a breakdown of the top automakers with the most recalls in 2024:

Tesla: 5.1 million vehicles recalled, primarily for issues fixable via over-the-air (OT
TSLA
leverage102 leverage102 9 minutes ago
MULN: Made a flip today, and back in for a double. One update away from dollars; imo.
MULN
janice shell janice shell 10 minutes ago
I didn't realizing she was hiding them.

True...
jour_trader jour_trader 10 minutes ago
Agree, depends on market size of onc market they are in. I was speaking in general, but yes you're 100% right. Market size for R&D onc companies will help determine buyout price.
ELTP
Lyly Lyly 10 minutes ago
also to you, cheers!
FKST
arizona1 arizona1 11 minutes ago
Why don't you own a Tesla now?
thecrusher2011 thecrusher2011 11 minutes ago
I found this whole "scandal" refreshing.

We found out that the Trump administration's public persona of not liking the two-faced con artists in Europe ripping us off for two generations and having us pay to defend them all these years while they laughed behind our backs matched what
arizona1 arizona1 11 minutes ago
Not even close to being the same but nice try

Okay what's the difference roosty?
jour_trader jour_trader 12 minutes ago
Most get snatched up in R&D phase at nice prices. 
ELTP
ilovetech ilovetech 12 minutes ago
The analysis didn't say manufacturing wouldn't start with artisan first.
NWBO
boi568 boi568 12 minutes ago
For purposes of our discussion, his co-workers.
AVXL
arizona1 arizona1 13 minutes ago
Wrong as usual zona! Bought low and still up a lot

Prove it.
Green Leaf Smoker Green Leaf Smoker 13 minutes ago
MJNA .... https://investorshub.advfn.com/uimage/uploads/2023/1/7/xmwbvih2-bear.png ....Bearish
https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1cqursl*_gcl_au*OTA1MjAwNDc2LjE3NDExMTYwODY.
MJNA
mrwrn2010 mrwrn2010 14 minutes ago
Agree. But often times, the onc pharma will have nothing at all or pocket change. Lol.
Ready to see another drug launch and a successful BE trial. Been a minute.
ELTP
flipper44 flipper44 16 minutes ago
Nope. Instead, the most recent ASM occurred seven months after the MAA filing. Within the thick of the evaluation process, LP stated, on June 29th, 2024 that commercial would begin with commercial artisan manufacturing.
NWBO
ilovetech ilovetech 16 minutes ago
Yep, it's well reasoned. Certainly would explain things...
NWBO
B402 B402 16 minutes ago
Before they reached 30,000 texts its good they got caught early on.....
Werbe Werbe 17 minutes ago
Fresh pr here would setup a nice climb.
EAWD
NoMoDo NoMoDo 17 minutes ago
1.6bil left, but who is counting? It isn't a share selling scam. It was a real attempt at something big.
HMBL
TRIPLE_ZERO_SEVEN TRIPLE_ZERO_SEVEN 18 minutes ago
A dynamic leader? Ha!
NICH
$7.00 or Nothing $7.00 or Nothing 18 minutes ago
Jour allow me to disagree

British drugmaker GSK (GSK.L), opens new tab said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of tumour.

Vs Vyvanse and adderall generics wit
ELTP
Monroe1 Monroe1 19 minutes ago
Mine too! And I buy anything below .001 !!!
Shorts and flippers have to post daily. They trade for the short haul.
So they post nonsense and post endlessly. Pay them no heed.
Try not to play their game. Building any business is a long and difficult process
and short ga
NBRI